Saturday, November 23, 2024
HomeTagsAVS100

AVS100

Avstera Therapeutics Receives FDA Orphan Drug Designation on AVS100 for Treatment of Advanced Stage Melanoma

Avstera Therapeutics Corp, an oncology-focused biotech dedicated to address the large disease burden and significant unmet need of cancer patients, has announced that the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics